Dr. Matthew Thompson, who has served as chief medical officer at Endologix since 2016, has been promoted to CEO of the vascular disease treatments company. Richard Mott, who has been serving as interim CEO, will return to his role as executive chair of the company’s board of directors, Endologix announced November 10. On top of […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Abbott research highlights issues with training, technology for treating cardiovascular disease
Abbott (NYSE:ABT) today released global market research that demonstrates challenges associated with the diagnosis and treatment of cardiovascular disease. From the company’s Beyond Intervention multi-year global research program, the latest research identified inconsistencies in patient care delivery, access to technology that supports accurate diagnosis and issues of health equity resulting in inadequate care for underserved […]
Vektor Medical wins FDA clearance for arrhythmia-identifying ECG mapping system
Vektor Medical announced that it received FDA 510(k) clearance for its novel vMap ECG mapping system for spotting potential arrhythmia sources. San Diego-based Vektor designed vMap to find hot spots in the form of arrhythmia sources associated with stable or unstable arrhythmias anywhere in the heart. That includes all four chambers, the septal wall and […]
FDA clears HeartVista’s MRI automation platform for Siemens Healthineers scanners
HeartVista announced today that it received FDA 510(k) clearance for its artificial intelligence-assisted One Click MRI acquisition software. Palo Alto, California-based HeartVista’s One Click MRI software received the FD clearance for delivery on Siemens Healthineers’ MRI scanners. The company said in a news release that its AI-assisted solutions make cardiac magnetic resonance (CMR) exams on […]
Medtronic reports promising early data for transfemoral delivery of its Intrepid TMVR
Medtronic (NYSE:MDT) this week touted data for its Intrepid self-expanding transcatheter mitral valve replacement (TMVR) system. Early data from 15 patients in an early feasibility study was presented as late-breaking clinical science at the 33rd Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of the Cardiovascular Research Foundation. The study evaluated patients with severe, symptomatic […]
FDA clears AFib notification on Apple Watch
An FDA letter confirms that Apple (NSDQ:AAPL) received 510(k) clearance for an irregular heart rhythm notification on the Apple Watch. The letter, dated October 22, stated that, after reviewing Apple’s 510(k) premarket notification of intent to market the device, the FDA determined that the device is substantially equivalent to legally marketed predicate devices for the […]
Edwards touts trial results for Evoque transcatheter tricuspid valve replacement system
Edwards Lifesciences (NYSE:EW) shared data from a clinical trial showing that its Evoque transcatheter tricuspid valve replacement offers favorable patient outcomes. Irvine, California–based Edwards presented the data during the late-breaking clinical science session at the 33rd Transcatheter Cardiovascular Therapeutics (TCT), according to a news release. The study evaluated 132 patients (56 patients with six-month follow-up) […]
Philips to acquire AI-powered cardiac diagnostic technology developer Cardiologs
Royal Philips (NYSE:PHG) announced today that it signed an agreement to acquire Cardiologs and its artificial intelligence (AI)-based technology. Amsterdam-based Philips said in a news release that France-based Cardiologs and its AI and cloud technology will further strengthen its cardiac monitoring and diagnostics offerings with innovative software, electrocardiogram (ECG) analysis and reporting services. Financial terms […]
Boston Scientific says Watchman FLX proved superior to Abbott’s Amplatzer Amulet
Data from a new study revealed that Boston Scientific’s (NYSE:BSX) Watchman FLX stroke prevention device outperformed Abbott’s (NYSE:ABT) Amplatzer Amulet. The results of the study exclusively comparing the next-generation Watchman FLX left atrial appendage closure (LAAC) and Amplatzer Amulet devices were presented at the Cardiovascular Research Foundation’s 2021 TCT meeting, according to the study’s abstract. Findings from […]
Abbott’s next-gen MitraClip G4 demonstrates improved quality of life in clinical trial
Abbott (NYSE:ABT) today publicized data from a global clinical trial of its MitraClip G4 for treating mitral regurgitation (MR). MitraClip G4, the fourth generation of Abbott’s MitraClip devices, demonstrated MR reduction to ≤1+ in the vast majority (91%) of patients and significantly improved New York Heart Association (NYHA) class and quality of life in the […]
Data shows safety and strong performance for Penumbra’s Indigo CAT RX catheter
Penumbra (NYSE:PEN) announced today that the Cheetah clinical study for its Indigo CAT RX catheter met its primary endpoint. Alameda, California-based Penumbra’s Indigo catheter system demonstrated high rates of blood clot removal, blood flow restoration and myocardial perfusion in conjunction with percutaneous coronary intervention (PCI) in patients with high thrombus burden. The company presented the […]